CLASS II ONGOING Device recall · Reported 28 Jan 2026 · FDA Enforcement Report

RayStation/RayPlan recalled by Raysearch Laboratories Ab

Raysearch Laboratories Ab is recalling RayStation/RayPlan. The recall was initiated on 28 Nov 2025 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI: 0735000201076120240508, 0735000201080820241217 GTIN: 07350002010761, 07350002010808 Serial Numbers: 15.1.0.852, 15.2.0.107 Software Revision: RayStation 2024A SP1, RayStation 2024A SP2 Expiration Date: 2030-04-15

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1108-2026
FDA event ID
98117
Recalling firm
Raysearch Laboratories Ab, Stockholm
Classification
Class II
Status
Ongoing
Recall initiated
28 Nov 2025
FDA classified
16 Jan 2026
Reported
28 Jan 2026
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Device Malfunction
Device type
Medical Software

Timeline

28 Nov 2025Recall initiated by company
16 Jan 2026Classified by FDA+49 days
28 Jan 2026Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Potential for the invalidation for calculated radiation dose does not work as intended for certain Regions of Interest (ROIs). This issue occurs for some ROI(s) which have no contours and either have a material override defined, or are of type Bolus, Fixation, or Support. In these cases, adding geometry to the ROI, subsequently modifying geometry, or removing the material override does not invalidate dose as intended.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

Brand Name: RayStation Product Name: RayStation/RayPlan Model/Catalog Number: 15.2.0, 15.1.3 Software Version: RayStation 2024A SP1, RayStation 2024A SP2 Product Description: Radiation Therapy Treatment Planning System Component: No

Where it was distributed

Refer to the attached documents: Distribution list 167168 US - updated, Distribution list 167168 OUS

Questions about this recall

Is RayStation/RayPlan recalled?

Yes. Raysearch Laboratories Ab recalled RayStation/RayPlan on 28 Nov 2025. The recall is Class II and its status is Ongoing. Recall number Z-1108-2026.

Why was it recalled?

Potential for the invalidation for calculated radiation dose does not work as intended for certain Regions of Interest (ROIs). This issue occurs for some ROI(s) which have no contours and either have a material override defined, or are of type Bolus, Fixation, or Support. In these cases, adding geometry to the ROI, subsequently modifying geometry, or removing the material override does not invalidate dose as intended.

Which lots are affected?

UDI: 0735000201076120240508, 0735000201080820241217 GTIN: 07350002010761, 07350002010808 Serial Numbers: 15.1.0.852, 15.2.0.107 Software Revision: RayStation 2024A SP1, RayStation 2024A SP2 Expiration Date: 2030-04-15

Where was it sold?

Refer to the attached documents: Distribution list 167168 US - updated, Distribution list 167168 OUS

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Raysearch Laboratories Ab

All 115

Other Medical Software recalls

All 903